(HALO) Halozyme Therapeutics BollingerBands charts technical analysis
(HALO) Halozyme Therapeutics BollingerBands charts technical analysis BollingerBands analysis of Halozyme Therapeutics | Buy/Sell Halozyme Therapeutics
Halozyme Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Halozyme Therapeutics is 1811250
| Date | Closing Price | Open | High | Low | Volume |
| 03 Thu Apr 2025 | 61.92 | 62.07 | 63.14 | 61.23 | 1.883 Mn |
| 02 Wed Apr 2025 | 63.02 | 61.70 | 63.14 | 61.54 | 1.574 Mn |
| 01 Tue Apr 2025 | 61.87 | 64.06 | 64.17 | 61.43 | 1.408 Mn |
| 31 Mon Mar 2025 | 63.81 | 63.39 | 64.07 | 62.60 | 1.642 Mn |
| 28 Fri Mar 2025 | 63.84 | 64.35 | 64.35 | 62.72 | 1.267 Mn |
| 24 Mon Mar 2025 | 64.02 | 65.69 | 66.00 | 62.85 | 2.4 Mn |
| 21 Fri Mar 2025 | 65.16 | 64.32 | 65.21 | 63.50 | 4.001 Mn |
| 20 Thu Mar 2025 | 64.32 | 63.91 | 64.94 | 63.88 | 1.637 Mn |
| 19 Wed Mar 2025 | 64.30 | 62.59 | 64.55 | 62.52 | 1.372 Mn |
| 18 Tue Mar 2025 | 62.54 | 62.62 | 63.18 | 62.13 | 1.226 Mn |
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 63.72 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
BollingerBands charts
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 63.72 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.